Table 6.

Mean utility values by self-reported HH-related comorbidities

HH-related comorbiditiesa	mean HSUV	SD	n
All participants
no comorbidity	0.76	0.21	100
arthritis	0.52	0.25	35
fibrosis	0.53	0.29	7
cirrhosis	0.61	0.31	5
heart failure	0.58	0.24	3
cardiomyopathy	0.30	-	1
diabetes	0.52	0.33	4
porphyria cutanea tarda	0.02	-	1
Males
no comorbidity	0.76	0.25	39
arthritis	0.59	0.23	15
fibrosis	0.69	0.05	5
cirrhosis	0.74	0.16	3
Females
no comorbidity	0.76	0.19	61
arthritis	0.48	0.26	20
fibrosis	0.12	0.02	2
cirrhosis	0.42	0.45	2

Note: HSUV refers to health state utility values; SD standard deviation

^aParticipants were asked if they had been diagnosed with these conditions and that they were considered to be related to HH and iron overload. Participants with these conditions, but were unsure if they were related to HH were not included in this analysis